Oral Answers to Questions

Lucy Frazer Excerpts

Thursday 1st December 2016 Commons Chamber

[Mr Davis]

The hon. Gentleman should perhaps make his point about industry collapsing to Google, Facebook, Microsoft, Nissan, GSK, Jaguar Land Rover and the rest. To come to his substantive point, we consider every request from Select Committees on its individual merits. There are probably something of the order of 30 ongoing projects at the moment. Frankly, if we appeared in front of every Select Committee on all those, we would not have any time to do any negotiation or planning at all.

[Lucy Frazer (South East Cambridgeshire) (Con)]

9. What representations the Government have received from the science and technology sector on priorities for its negotiations on the UK leaving the EU.

[Mrs Cheryl Gillan (Chesham and Amersham) (Con)]

13. What representations the Government has received from the science and technology sector on priorities for its negotiations on the UK leaving the EU.

--- Later in debate ---

[Lucy Frazer]

I thank the Minister for that answer. The life sciences and pharma sectors are concerned that they need globally recognised and equivalent regulations to compete internationally. Can the Minister assure me that he will continue to work closely with these sectors to ensure they have the best possible opportunities in the Brexit negotiations?

[Mr Walker]

My hon. and learned Friend is right, and the Government are committed to ensuring a positive outcome for the UK’s life sciences and the pharmaceuticals sector as we exit the European Union. We have welcomed many hundreds of millions of pounds of new investment from Alnylam and GSK, and I can assure her that Ministers in our Department are engaging, and will continue to engage, with the pharma and life sciences industry to ensure that we take the opportunities as well as meet the challenges ahead.